About Erenumab
Class: | Calcitonin gene-related peptide (CGRP) receptor antagonist
Use: | Preventive treatment of migraine in adults
Adult dose: | 70 mg subcutaneously once monthly; may consider 140 mg subcutaneously once monthly for patients who do not achieve adequate response
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years
Side effects: | Injection site reactions, constipation, muscle cramps, and hypersensitivity reactions
Contraindications: | Hypersensit
Drug Class
Calcitonin gene-related peptide (CGRP) receptor antagonist
Uses & Indications
Preventive treatment of migraine in adults
Storage Requirements
Store in the refrigerator (2°C to 8°C); may be stored at room temperature (up to 25°C) for up to 7 days; do not freeze
Manufacturer & Packaging
Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A
Package Size
Prefilled Pen
Price & Supplier
Price in UAE: AED 2477.00
Dosage Information
Adult Dose
70 mg subcutaneously once monthly; may consider 140 mg subcutaneously once monthly for patients who do not achieve adequate response
Pediatric Dose
Safety and efficacy not established in pediatric patients under 18 years
Side Effects
Injection site reactions, constipation, muscle cramps, and hypersensitivity reactions
Contraindications & Precautions
Hypersensitivity to erenumab or any component of the formulation; history of serious allergic reactions
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of allergic reactions; not recommended for use in patients with a history of cardiovascular disease without consulting a healthcare provider
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.